Health

mRNA Cancer Vaccine Breakthrough For Melanoma

22 Oct to 23 Oct

8 outlets

Each outlet's article on this story, most articles first

8 articles

8 reporters

Julie SteenhuysenThe Independent
Michael ErmanThe Independent
Lauran NeergaardToronto Star
Alice ParkTime
Joanna HyndsDaily Mail
Rachel CarbonellABC News (AU)
Jim ReedBBC
Jane KirbyEvening Standard

By day

Articles per day

Save

Cite

APA MLA Chicago

mRNA Cancer Vaccine Breakthrough For Melanoma. (2026, October 23). The Aporia. https://the-aporia.com/event/100195

Dated the day this page was built. The link always leads to this event, even after the stories are regrouped.

Sources (CSV) · Sources (JSON)

Photo via Evening Standard

Photo via BBC

Photo via ABC News (AU)

The landmark findings could pave the way for personalised cancer vaccines to improve survival rates for patients with melanoma and potentially other cancers.

What happened

The outlets' own sentences, most widely reported first. Hover one for who reported it.

The study included more than 1,100 people with high-risk melanoma that was surgically removed.

6 of 8 outletsfirst reported 22 Octwording from Toronto Star

Among subjects who received the vaccine paired with Keytruda, 82.2% remained cancer-free after two years, compared to 70% of those who received Keytruda alone.

4 of 8 outletsfirst reported 22 Octwording from The Independent

The vaccine, called intismeran, is made with the same Nobel Prize-winning mRNA technology that was behind COVID-19 vaccines.

4 of 8 outletsfirst reported 22 Octwording from Toronto Star

Moderna shares closed more than 17% lower on Thursday after the trial findings leaked on an oncology website, despite having nearly quadrupled through Wednesday's close since August when the trial's success was first announced without full data.

3 of 8 outletsfirst reported 22 Octwording from The Independent

Analysis

Agreed

Reported by outlets on both sides of the middle

No sentence was reported across the range.

Disputed

Picked by our model, which is sometimes wrong

No disagreement the check could confirm. That does not prove there is none.

Framing

How the first headlines put it

Stated as fact7

How it changed

22 Oct
WASHINGTON (AP) — A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
7 outlets · Toronto Star
23 Oct
Intismeran, developed jointly by Moderna and Merck, represents a new way to harness the immune system in cancer, by training immune cells to recognize 34 specific proteins on tumor cells.
2 outlets · Time

Coverage 8 articles

23 Oct A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study
CBC
23 Oct World’s first mRNA cancer jab for melanoma cuts risk of death by 42%
Evening Standard
23 Oct First personalised cancer vaccine cuts risk of disease returning in major trial
BBC
23 Oct Australia at the heart of 'transformational' cancer vaccine breakthrough
ABC News (AU)
23 Oct World-first cancer vaccine slashes death risk in stunning findings led by Aussie scientist
Daily Mail
23 Oct A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
Time
22 Oct A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Toronto Star
22 Oct mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%
The Independent

Built 2026-10-23 from 8 articles. Every sentence on this page is quoted from the linked article; nothing was written by a model except the Summary and the items marked AI, which cite their sources, and the questions and labels under "Disputed". Photos are from the outlets that covered the story, never from articles our check marks sensitive.